Effectiveness, safety and costs of the FreeStyle Libre glucose monitoring system for children and adolescents with type 1 diabetes in Spain: a prospective, uncontrolled, pre-post study

Himar González-Pacheco, Amado Rivero-Santana, Yolanda Ramallo-Fariña, Cristina Valcárcel-Nazco, Yolanda Álvarez-Pérez, Lidia García-Pérez, Miguel Angel García-Bello, Lilisbeth Perestelo-Pérez, Pedro Serrano-Aguilar · 2023

Read Effectiveness, safety and costs of the FreeStyle Libre glucose monitoring system for children and adolescents with type 1 diabetes in Spain: a prospective, uncontrolled, pre-post study by Himar González-Pacheco, Amado Rivero-Santana, Yolanda Ramallo-Fariña, Cristina Valcárcel-Nazco, Yolanda Álvarez-Pérez, Lidia García-Pérez, Miguel Angel García-Bello, Lilisbeth Perestelo-Pérez, Pedro Serrano-Aguilar (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10729222.txt.

Description

Himar González-Pacheco and co-authors published this study in 2023. It evaluates the FreeStyle Libre flash glucose monitor in Spanish children and adolescents with type 1 diabetes, tracking effectiveness, safety, and costs over a year in thirteen public hospitals.

One hundred fifty-six young patients were measured before and after adopting the sensor. Overall, average blood sugar control slightly worsened, driven by patients who started well controlled. The subgroup starting in poor control improved clearly at every checkpoint. Severe hypoglycemia, the dangerous lows, fell significantly across the whole group. Satisfaction rose; quality of life and diabetes knowledge did not change. Teenagers wore the sensor less and scanned less than younger children, and sticking with the device tracked better results. No serious device harms appeared, and savings on test strips plus parents' recovered work time offset costs. The authors counsel targeting the device first to poorly controlled patients.

Catalog record

CREATORHimar González-Pacheco, Amado Rivero-Santana, Yolanda Ramallo-Fariña, Cristina Valcárcel-Nazco, Yolanda Álvarez-Pérez, Lidia García-Pérez, Miguel Angel García-Bello, Lilisbeth Perestelo-Pérez, Pedro Serrano-Aguilar
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10729222

Browse the full library · About the Tower of Babel